Sofia, Bulgaria, December 23, 2020 - According to the requirements of art. 100t of LPOS, 'Sopharma' AD (3JR: 'BSE-Sofia' AD, SPH: Warsaw Stock Exchange) notifies that the Board of Directors gave a mandate to the Executive director and the Procurator of the company to negotiate for the sale of the shares owned by 'Sopharma' AD in its subsidiaries 'Veta Pharma' AD and 'Aromania' AD.
- Add to folder
- Page folder
Attachments
- Original document
- Permalink
Disclaimer
Sopharma AD published this content on 23 December 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 December 2020 05:42:04 UTC